Palis Bryan E, Janczewski Lauren M, Browner Amanda E, Cotler Joseph, Nogueira Leticia, Richardson Lisa C, Benard Vicki, Wilson Reda J, Walker Nadine, McCabe Ryan M, Boffa Daniel J, Nelson Heidi
American College of Surgeons, Chicago, IL, USA.
American Cancer Society, Atlanta, USA.
Ann Surg Oncol. 2024 Sep;31(9):5546-5559. doi: 10.1245/s10434-024-15393-8. Epub 2024 May 8.
Standardization of procedures for data abstraction by cancer registries is fundamental for cancer surveillance, clinical and policy decision-making, hospital benchmarking, and research efforts. The objective of the current study was to evaluate adherence to the four components (completeness, comparability, timeliness, and validity) defined by Bray and Parkin that determine registries' ability to carry out these activities to the hospital-based National Cancer Database (NCDB).
Tbis study used data from U.S. Cancer Statistics, the official federal cancer statistics and joint effort between the Centers for Disease Control and Prevention (CDC) and the National Cancer Institute (NCI), which includes data from National Program of Cancer Registries (NPCR) and Surveillance, Epidemiology, and End Results (SEER) to evaluate NCDB completeness between 2016 and 2020. The study evaluated comparability of case identification and coding procedures. It used Commission on Cancer (CoC) standards from 2022 to assess timeliness and validity.
Completeness was demonstrated with a total of 6,828,507 cases identified within the NCDB, representing 73.7% of all cancer cases nationwide. Comparability was followed using standardized and international guidelines on coding and classification procedures. For timeliness, hospital compliance with timely data submission was 92.7%. Validity criteria for re-abstracting, recording, and reliability procedures across hospitals demonstrated 94.2% compliance. Additionally, data validity was shown by a 99.1% compliance with histologic verification standards, a 93.6% assessment of pathologic synoptic reporting, and a 99.1% internal consistency of staff credentials.
The NCDB is characterized by a high level of case completeness and comparability with uniform standards for data collection, and by hospitals with high compliance, timely data submission, and high rates of compliance with validity standards for registry and data quality evaluation.
癌症登记处数据提取程序的标准化对于癌症监测、临床和政策决策、医院基准评估以及研究工作至关重要。本研究的目的是评估对布雷和帕金定义的四个要素(完整性、可比性、及时性和有效性)的遵循情况,这些要素决定了登记处开展这些活动的能力,对象是基于医院的国家癌症数据库(NCDB)。
本研究使用了美国癌症统计数据,这是官方的联邦癌症统计数据,由疾病控制与预防中心(CDC)和国家癌症研究所(NCI)共同努力得出,其中包括来自国家癌症登记计划(NPCR)和监测、流行病学与最终结果(SEER)的数据,以评估2016年至2020年期间NCDB的完整性。该研究评估了病例识别和编码程序的可比性。它采用2022年癌症委员会(CoC)的标准来评估及时性和有效性。
NCDB共识别出6,828,507例病例,证明了其完整性,占全国所有癌症病例的73.7%。通过使用编码和分类程序的标准化和国际准则来保证可比性。在及时性方面,医院及时提交数据的合规率为92.7%。各医院重新提取、记录和可靠性程序的有效性标准显示合规率为94.2%。此外,数据有效性表现为组织学验证标准的合规率为99.1%,病理概要报告的评估率为93.6%,工作人员资质的内部一致性为99.1%。
NCDB的特点是病例完整性高,数据收集标准统一,各医院合规性高、数据提交及时,且在登记处和数据质量评估的有效性标准方面合规率高。